210 related articles for article (PubMed ID: 26427403)
1. Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.
Agbaga MP
Adv Exp Med Biol; 2016; 854():129-35. PubMed ID: 26427403
[TBL] [Abstract][Full Text] [Related]
2. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
3. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
[TBL] [Abstract][Full Text] [Related]
4. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
Agbaga MP; Logan S; Brush RS; Anderson RE
Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
[TBL] [Abstract][Full Text] [Related]
6. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
Bennett LD; Anderson RE
Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
[TBL] [Abstract][Full Text] [Related]
7. ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.
Hopiavuori BR; Anderson RE; Agbaga MP
Prog Retin Eye Res; 2019 Mar; 69():137-158. PubMed ID: 30982505
[TBL] [Abstract][Full Text] [Related]
8. Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.
Deák F; Anderson RE; Fessler JL; Sherry DM
Front Cell Neurosci; 2019; 13():428. PubMed ID: 31616255
[TBL] [Abstract][Full Text] [Related]
9. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
10. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
[TBL] [Abstract][Full Text] [Related]
11. Very long chain fatty acid-containing lipids: a decade of novel insights from the study of ELOVL4.
Yeboah GK; Lobanova ES; Brush RS; Agbaga MP
J Lipid Res; 2021; 62():100030. PubMed ID: 33556440
[TBL] [Abstract][Full Text] [Related]
12. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.
Agbaga MP; Brush RS; Mandal MN; Henry K; Elliott MH; Anderson RE
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12843-8. PubMed ID: 18728184
[TBL] [Abstract][Full Text] [Related]
13. ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.
Yu M; Benham A; Logan S; Brush RS; Mandal MNA; Anderson RE; Agbaga MP
J Lipid Res; 2012 Mar; 53(3):494-504. PubMed ID: 22158834
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of very long-chain fatty acids (C>24) in Atlantic salmon: cloning, functional characterisation, and tissue distribution of an Elovl4 elongase.
Carmona-Antoñanzas G; Monroig O; Dick JR; Davie A; Tocher DR
Comp Biochem Physiol B Biochem Mol Biol; 2011 Jun; 159(2):122-9. PubMed ID: 21377536
[TBL] [Abstract][Full Text] [Related]
15. Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.
Cadieux-Dion M; Turcotte-Gauthier M; Noreau A; Martin C; Meloche C; Gravel M; Drouin CA; Rouleau GA; Nguyen DK; Cossette P
JAMA Neurol; 2014 Apr; 71(4):470-5. PubMed ID: 24566826
[TBL] [Abstract][Full Text] [Related]
16. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival.
Cameron DJ; Tong Z; Yang Z; Kaminoh J; Kamiyah S; Chen H; Zeng J; Chen Y; Luo L; Zhang K
Int J Biol Sci; 2007 Feb; 3(2):111-9. PubMed ID: 17304340
[TBL] [Abstract][Full Text] [Related]
17. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
[TBL] [Abstract][Full Text] [Related]
18. Examination of VLC-PUFA-deficient photoreceptor terminals.
Bennett LD; Hopiavuori BR; Brush RS; Chan M; Van Hook MJ; Thoreson WB; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4063-72. PubMed ID: 24764063
[TBL] [Abstract][Full Text] [Related]
19. Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.
Agbaga MP; Mandal MN; Anderson RE
J Lipid Res; 2010 Jul; 51(7):1624-42. PubMed ID: 20299492
[TBL] [Abstract][Full Text] [Related]
20. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
